Orthofix Medical Inc. Selling, General and Administrative Expense
Orthofix Medical Inc. (OFIX) reported Selling, General and Administrative Expense of $138.03 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-05
- Orthofix Medical Inc. selling, general and administrative expense for the quarter ending 2026-06-30 was $138.03M, a 1.13% increase year-over-year.
- Orthofix Medical Inc. selling, general and administrative expense for the quarter ending 2026-03-31 was $134.91M, a 1.45% increase year-over-year.
- Orthofix Medical Inc. selling, general and administrative expense for the quarter ending 2025-12-31 was $136.75M, a 0.20% increase year-over-year.
- Orthofix Medical Inc. selling, general and administrative expense for the quarter ending 2025-09-30 was $148.10M, a 13.80% increase year-over-year.
- Orthofix Medical Inc. selling, general and administrative expense for fiscal 2025 was $554.33M, a 4.09% increase from fiscal 2024.
- Orthofix Medical Inc. selling, general and administrative expense for fiscal 2024 was $532.52M, a 0.40% increase from fiscal 2023.
- Orthofix Medical Inc. selling, general and administrative expense for fiscal 2023 was $530.39M, a 71.77% increase from fiscal 2022.
- Orthofix Medical Inc. selling, general and administrative expense for fiscal 2022 was $308.78M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $138.03M 10-Q · filed 2026-08-05 | $272.94M 10-Q · filed 2026-08-05 | $409.69M derived: sum of 3 quarters · filed 2026-08-05 | $557.80M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $134.91M 10-Q · filed 2026-05-05 | $271.66M derived: sum of 2 quarters · filed 2026-05-05 | $419.77M derived: sum of 3 quarters · filed 2026-05-05 | $556.26M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $136.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $284.86M derived: sum of 2 quarters · filed 2026-02-24 | $421.35M derived: sum of 3 quarters · filed 2026-08-05 | $554.33M 10-K · filed 2026-02-24 |
| 2025-09-30 | $148.10M 10-Q · filed 2025-11-04 | $284.60M derived: sum of 2 quarters · filed 2026-08-05 | $417.58M 10-Q · filed 2025-11-04 | $554.05M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $136.49M 10-Q · filed 2026-08-05 | $269.47M 10-Q · filed 2026-08-05 | $405.95M derived: sum of 3 quarters · filed 2026-08-05 | $536.09M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $132.98M 10-Q · filed 2026-05-05 | $269.46M derived: sum of 2 quarters · filed 2026-05-05 | $399.60M derived: sum of 3 quarters · filed 2026-05-05 | $533.82M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $136.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $266.62M derived: sum of 2 quarters · filed 2026-02-24 | $400.83M derived: sum of 3 quarters · filed 2026-02-24 | $532.52M 10-K · filed 2026-02-24 |
| 2024-09-30 | $130.14M 10-Q · filed 2025-11-04 | $264.36M derived: sum of 2 quarters · filed 2025-11-04 | $396.05M 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $134.22M 10-Q · filed 2025-08-05 | $265.91M 10-Q · filed 2025-08-05 | ||
| 2024-03-31 | $131.69M 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | $530.39M 10-K · filed 2026-02-24 | |||
| 2022-12-31 | $308.78M 10-K · filed 2025-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |